Profile (as of April 2021)
|Company name||Lilac pharma Inc.|
|Address||Room #C, Hokkaido Collaboration Center (Collabo Hokkaido Bldg.)
North 21, West 12, Kita-ku, Sapporo, Hokkaido 001-0021, Japan
|Business||1. Research and development of pharmaceutical products etc.
2. Licensing and trading intellectual properties.
3. Investigation and consultation pertaining to the research and development of pharmaceutical products etc.
|Date of establishment||April 18, 2016|
|Capital||14.1 million yen|
|Management||President Motoki Susa, PhD
Director Makiyo Sato, lawyer
Auditor Taihei Muramoto, SME Management Consultant
|Adviser||Hisao Shiozawa, Patent attorney, SIKS &Co. (IP firm)|
|Mar. 2016||Awarded the Grand Prize in the SAPPORO Venture Grand Prix 2015 (in the name of Motoki Susa).|
|Mar. 2016||Awarded a grant of 35 million yen from the NEDO (New Energy and Industrial Technology Development Organization, Japan) (in the name of Hokkaido univ. entrepreneur team).|
|Apr. 2016||Established in Sapporo city.|
|Jun. 2016||Certified by Hokkaido University as a university spin-off company.|
|Jan. 2018||Raised 10 million yen in seed-round financing from Hokuyo fund.|
|Apr. 2018||iLiNP business launched.|
Origin of Company name
Lilac likes a cool place and we can see mainly in Hokkaido, Japan. It was chosen as a “Tree of Sapporo city” in 1960 and it is familiar to many citizens now.
Lilac’s petals are usually 4 pieces, but rarely 5 pieces. If you find the rare flower and swallow it silently, it’s said that you can spend eternally with a person who loves.
We’d like to create the pharmaceutical products, which become the “5th Lilac petal” for patients, and decided to include our feelings in this Company’s name.